FDA Implantable Middle Ear Draft Guidance Follows Panel Recommendations
This article was originally published in The Gray Sheet
Executive Summary
Direct comparisons of conventional hearing aids to implantable middle ear hearing devices should be performed when preparing a premarket approval application, according to an FDA 1draft guidance
You may also be interested in...
Implantable Middle Ear Hearing Device Control Comparison Weighed By CDRH
FDA will need to decide whether a planned guidance on implantable middle ear hearing devices should allow sponsors to control against unaided conditions
FDA In Brief
August ENT panel meeting: FDA's Ear Nose and Throat Devices Panel will meet Aug. 16 in Gaithersburg, Maryland to discuss and make recommendations on the recently issued implantable middle ear hearing device draft guidance (1"The Gray Sheet" June 17, 2002, p. 11). Topics to be addressed include "appropriate study population, objective measurement techniques for comparison of acoustic hearing aids and middle ear hearing devices and subjective questionnaire development for determining postoperative effectiveness and quality of life outcomes," according to the 2ENT meeting announcement. Requests for formal oral presentations should be submitted to FDA by Aug. 8...
FDA In Brief
August ENT panel meeting: FDA's Ear Nose and Throat Devices Panel will meet Aug. 16 in Gaithersburg, Maryland to discuss and make recommendations on the recently issued implantable middle ear hearing device draft guidance (1"The Gray Sheet" June 17, 2002, p. 11). Topics to be addressed include "appropriate study population, objective measurement techniques for comparison of acoustic hearing aids and middle ear hearing devices and subjective questionnaire development for determining postoperative effectiveness and quality of life outcomes," according to the 2ENT meeting announcement. Requests for formal oral presentations should be submitted to FDA by Aug. 8...